Suspension of trading
Sector Merrimack Pharmaceuticals
Stocks
MACK
US5903282094
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.13 USD | -0.13% |
|
-.--% | - |
| 21/05/24 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
| 21/05/24 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.13% | -.--% | -.--% | -.--% | -.--% | -.--% | +26.51% | +144.43% | -72.49% | 224M | |
| +1.07% | -3.49% | +3.71% | +14.21% | +1.90% | -3.25% | +12.87% | -22.34% | +201.60% | 46.86B | |
| +0.25% | +1.65% | +11.46% | +39.86% | +137.58% | +408.41% | +629.49% | +553.87% | - | 40.23B | |
| -0.27% | +4.45% | +17.60% | +8.34% | +7.27% | +9.93% | +66.92% | +2.83% | +1,093.77% | 36.23B | |
| +0.35% | +0.87% | +12.08% | +28.20% | -7.70% | +3.60% | -8.81% | -16.47% | +181.03% | 34.72B | |
| +3.14% | +1.02% | +2.84% | -10.78% | +3.03% | +3.37% | +38.15% | -19.55% | +142.32% | 27.89B | |
| -0.73% | +11.84% | +17.28% | +46.49% | +7.07% | +31.97% | +143.53% | +230.21% | - | 16.79B | |
| +0.47% | -2.74% | +6.66% | +10.73% | - | - | - | - | - | 16.74B | |
| +0.42% | -5.52% | -0.93% | +7.44% | +6.41% | +0.76% | +8.50% | -35.47% | +95.27% | 13.12B | |
| -2.68% | -2.49% | +4.80% | +62.24% | -9.03% | -15.00% | -31.68% | -23.96% | +129.78% | 12.7B | |
| -0.24% | -0.72% | +21.61% | +32.14% | +21.75% | +22.46% | -18.55% | -39.63% | +158.60% | 11.16B | |
| -1.48% | -5.37% | +39.78% | +17.50% | -6.31% | +93.48% | +542.37% | +259.81% | +2,678.33% | 11.07B | |
| -1.18% | +0.99% | +12.11% | +33.44% | +13.59% | +27.94% | +9.33% | -42.83% | +161.10% | 10.91B | |
| +0.01% | +0.21% | +1.20% | +56.85% | +77.90% | +222.48% | +560.83% | - | - | 10.08B | |
| -1.21% | +8.60% | +55.30% | +31.86% | +35.53% | +37.85% | +52.61% | -55.50% | - | 9.49B | |
| +1.22% | +3.97% | -26.10% | -22.82% | -28.52% | +34.16% | +44.11% | +48.70% | +103.12% | 9.35B | |
| +0.17% | -4.49% | +10.71% | +30.22% | +42.10% | +141.16% | +404.89% | +90.15% | - | 9.1B | |
| +0.90% | +3.46% | +5.30% | -5.66% | +10.37% | +460.81% | +1,985.26% | +32.32% | - | 9.07B | |
| -0.15% | +0.32% | +4.84% | +58.78% | +89.03% | +99.36% | +66.37% | +116.05% | +6.20% | 8.82B | |
| +0.50% | -3.41% | +11.43% | +36.11% | +55.84% | +153.28% | +595.15% | +189.47% | - | 8.75B | |
| Average | +0.02% | +0.25% | +10.58% | +23.76% | +24.09% | +91.20% | +269.89% | +78.45% | +406.55% | 17.16B | |
| Weighted average by Cap. | +0.29% | +0.56% | +10.54% | +22.53% | +26.70% | +90.05% | +217.97% | +91.75% | +432.23% |
- Stock Market
- Stocks
- MACK Stock
- Sector Merrimack Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
